Live Newswire18 stories on the wire
The Wire
Every headline that moves the tape, paired with the why, in plain English.
AllBreakingMarketsEconomyFederal ReserveEarningsCompanyAnalyst ActionsTechnologyEnergyCryptocurrency
Lead StoryAnalyst Actions11:00 AM ET
Bill Ackman Said ‘Hell Is Coming’ in 2020 — How a $27 Million Hedge Turned Into $2.6 Billion as He Bought the Crash
Bill Ackman turned a $27M COVID-era credit hedge into $2.6B, then bought discounted stocks during the 2020 market crash.
Why it
matters
matters
A big investor protected his money when markets crashed in 2020. Then he bought stocks at cheap prices and made huge profits.
AI-Generated · Educational · Not Advice
Read full story →Source · Benzinga
In this story
ReadNeutral
Latest17 stories
01:52 PM ETAnalyst Actions
This $3 Biotech Could Be Worth $11.45, Analyst Says
WhyAn analyst thinks this biotech company has a strong medicine platform. They believe the stock could be worth much more than today.
CATXLLYBMYSource · Benzinga
01:07 PM ETAnalyst Actions
Etsy Analyst Turns Bullish On 3 Positive Developments
WhyAn analyst believes Etsy is doing three things well: saving money, getting more shoppers, and selling more stuff. When smart money people feel more hopeful, it often means the company is moving in a better direction.
ETSYSource · Benzinga
01:05 PM ETAnalyst Actions
Netflix Viewer Trends 'Look Worrying': Wells Fargo Slashes Target on Stock
WhyA big investment firm thinks Netflix has fewer people watching and hit shows. When experts worry about a company, it's worth paying attention to what's changing.
NFLXWFCSource · Benzinga
12:59 PM ETAnalyst Actions
Grail Analyst Sees Massive Market Potential with Valuation Headwinds
WhyRBC thinks Grail's blood test could be really useful someday. But they say the stock price might be too high right now.
GRALILMNSource · Benzinga
12:08 PM ETAnalyst Actions
This Accenture Analyst Is No Longer Bullish Ahead Of Q4 Print
WhyAn expert said Accenture stock may not grow much soon. The company faces slow business and delayed customer deals.
ACNSource · Benzinga
12:00 PM ETAnalyst Actions
Eli Lilly Diabetes Drug Franchise Remains Strong, Analyst Praises Foundayo Trajectory
WhyAn expert thinks Eli Lilly's diabetes medicines are selling really well. This suggests the company is doing what it promised to do.
LLYSource · Benzinga
11:17 AM ETAnalyst Actions
Ciena’s 2029 Outlook Draws Positive Analyst Reactions
WhyCiena told investors it expects to grow revenue fast and make more profit by 2029. Analysts got excited about this plan and raised their price targets for the stock.
CIENNUMGSCHMSource · Benzinga
11:14 AM ETAnalyst Actions
Xenon Stock Reaction Is Overblown: Analyst
WhyXenon sent a seizure medicine to the FDA for approval. They paused depression studies, but one expert thinks people are too worried.
XENESource · Benzinga
09:17 AM ETAnalyst Actions
Ultragenyx Wins First Sanfilippo Approval As Analyst Keeps Ratings Modest
WhyUltragenyx got FDA approval for a new Sanfilippo disease medicine called Fayuvi. When a company wins approval, watch how well they sell it and if patients can afford it.
RARESource · Benzinga
08:49 AM ETAnalyst Actions
This Etsy Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
WhySome stock experts decided Etsy and a few other companies look better now. They raised their price targets, meaning they think these stocks could do well.
ETSYULTARFSource · Benzinga
08:48 AM ETAnalyst Actions
This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
WhySome experts changed their minds and became more worried about Netflix and other companies. When experts downgrade stocks, it means they think the company might face tougher times ahead.
MGAPANWPEGASource · Benzinga
08:46 AM ETAnalyst Actions
SB
B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23
WhyA Wall Street analyst started following Anika and thinks it looks good. This suggests the analyst sees reasons to believe the company could do well.
ANIKSource · Benzinga
08:40 AM ETAnalyst Actions
Stock Market Today: S&P 500, Dow Futures Pare Gains, Nasdaq 100 Up as Trump Weighs 'Big Decision' on Iran Military Strikes— OKLO, MCD, BB, NUE in Focus (UPDATED)
WhyThe stock market went up and down on Friday with mixed signals. When big news happens around the world, stocks can swing back and forth quickly.
SPYX:BTCUSDMCDSource · Benzinga
08:31 AM ETAnalyst Actions
Apple To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Friday
WhyDifferent analysts changed their price guesses for several stocks. When many experts shift their views, it shows they are rethinking what these companies are worth.
AAPLGOOGLNFLXSource · Benzinga
08:26 AM ETAnalyst Actions
Jefferies Financial Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
WhyJefferies will share its earnings results very soon. Smart analysts keep changing their guesses about how well the company did.
JEFSource · Benzinga
07:53 AM ETAnalyst Actions
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
WhyMultiple new analysts started watching five companies this week. They said they liked what they saw so far.
CUENPCENGVCSource · Benzinga
06:58 AM ETAnalyst Actions
Vail Resorts Likely To Report Q4 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
WhyVail Resorts will likely lose money this quarter based on analyst forecasts. When a company loses money, watch whether it bounces back next season or keeps struggling.
MTNSource · Benzinga
Educational commentary, not financial advice. No outcomes guaranteed. Headlines link to the original publisher.